Novo Nordisk gains approval to sell weight-loss drug Wegovy in China
Europe’s most valuable company said Chinese regulators have approved its marketing application to sell Wegovy as a long-term weight-loss treatment for patients with obesity.
Job prospects have improved since the pandemic for these often overlooked workers
One carrier is expected to lead all others by a wide margin for core profitability
Goldman Sachs technical strategist Scott Rubner said he expects a major rally in the S&P 500 index could push it...
Ford’s stock veered lower Wednesday, after the automaker reported a nice increase in third-quarter electric vehicles sales in the U.S.,...
A prolonged strike may lead to delayed shipments and deliveries to warehouses, notes one analyst.
Conagra’s stock was headed for a selloff on Wednesday after the maker of frozen foods and snacks suffered a rare...